REGISTER HERE –> https://bit.ly/3nLFhBr
Rapidly evolving therapeutic strategies coupled with advances in diagnostic have improved the efficacy of cancer care. Despite these welcomed advances in cancer care, therapy is complex, dynamic, and associated with considerable risk of medical and psychological complications. In addition cancer care is costly with approximately $200B in annual costs.
Last month, The Center for Medicare & Medicaid Innovation announced a new risk-based value based care program for Medicare beneficiaries undergoing cancer care. The program requires the implementation of electronic patient report outcomes and more structured attention to the mental health of patients.
Join us as Dr. Michael Seiden, an oncologist and former President of US Oncology, meets with Geoffrey Eich, CEO of Blue Note Therapeutics, and Lavi Kwiatkowsky, CEO of Canopy, as they discuss the role of their companies in improving the cancer care journey. This includes the opportunities and challenges in commercializing patient facing technology that offer the hope of both improving cancer care and reducing cancer care costs.
11:00 – 11:05 AM: Welcome from The Hive
11:05 – 11:15 AM: Introduction from Speakers
11:15 – 11:50 AM: Panel Discussion
11:50 – 12:00 PM: Audience Q&A